These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 15982438)

  • 1. Recombinant factor VII for severe bleeding during extracorporeal membrane oxygenation following open heart surgery.
    Wittenstein B; Ng C; Ravn H; Goldman A
    Pediatr Crit Care Med; 2005 Jul; 6(4):473-6. PubMed ID: 15982438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activated recombinant factor VII for refractory bleeding during extracorporeal membrane oxygenation.
    Niebler RA; Punzalan RC; Marchan M; Lankiewicz MW
    Pediatr Crit Care Med; 2010 Jan; 11(1):98-102. PubMed ID: 19561557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant factor seven therapy for postoperative bleeding in neonatal and pediatric cardiac surgery.
    Agarwal HS; Bennett JE; Churchwell KB; Christian KG; Drinkwater DC; He Y; Taylor MB
    Ann Thorac Surg; 2007 Jul; 84(1):161-8. PubMed ID: 17588404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant factor VIIa (NovoSeven) as a hemostatic agent after surgery for congenital heart disease.
    Razon Y; Erez E; Vidne B; Birk E; Katz J; Tamari H; Dagan O
    Paediatr Anaesth; 2005 Mar; 15(3):235-40. PubMed ID: 15725322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of recombinant activated factor VII for controlling refractory postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass.
    Pychyńska-Pokorska M; Pągowska-Klimek I; Krajewski W; Moll JJ
    J Cardiothorac Vasc Anesth; 2011 Dec; 25(6):987-94. PubMed ID: 21835642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant activated factor VII in cardiac surgery: experience from the Australian and New Zealand Haemostasis Registry.
    Dunkley S; Phillips L; McCall P; Brereton J; Lindeman R; Jankelowitz G; Cameron P
    Ann Thorac Surg; 2008 Mar; 85(3):836-44. PubMed ID: 18291152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activated recombinant factor VII for refractory bleeding during extracorporeal membrane oxygenation.
    Verrijckt A; Proulx F; Morneau S; Vobecky S
    J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1812-3. PubMed ID: 15173742
    [No Abstract]   [Full Text] [Related]  

  • 8. Defining the role of recombinant activated factor VII in pediatric cardiac surgery: where should we go from here?
    Warren OJ; Rogers PL; Watret AL; de Wit KL; Darzi AW; Gill R; Athanasiou T
    Pediatr Crit Care Med; 2009 Sep; 10(5):572-82. PubMed ID: 19451849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of recombinant activated factor VII for refractory hemorrhage in pediatric patients on extracorporeal membrane oxygenation: a single center review.
    Long MT; Wagner D; Maslach-Hubbard A; Pasko DA; Baldridge P; Annich GM
    Perfusion; 2014 Mar; 29(2):163-70. PubMed ID: 23942787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. rFVIIa in the treatment of persistent hemorrhage in pediatric patients on ECMO following surgery for congenital heart disease.
    Veldman A; Neuhaeuser C; Akintuerk H; Thul J; Gehron J; Schranz D; Michel-Behnke I
    Paediatr Anaesth; 2007 Dec; 17(12):1176-81. PubMed ID: 17986036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder.
    Yilmaz D; Karapinar B; Balkan C; Akisü M; Kavakli K
    Pediatr Hematol Oncol; 2008 Jun; 25(4):301-11. PubMed ID: 18484474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of recombinant activated factor VII concentrate to control postoperative hemorrhage in complex cardiovascular surgery.
    Bowman LJ; Uber WE; Stroud MR; Christiansen LR; Lazarchick J; Crumbley AJ; Kratz JM; Toole JM; Crawford FA; Ikonomidis JS
    Ann Thorac Surg; 2008 May; 85(5):1669-76; discussion 1676-7. PubMed ID: 18442563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factor VII for excessive bleeding following congenital heart disease surgery.
    Changlani DK; Devendaran V; Murmu UC; Ganesan S; Varghese R; Kumar RS
    Asian Cardiovasc Thorac Ann; 2012 Apr; 20(2):120-5. PubMed ID: 22499956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracorporeal membrane oxygenation circulatory support after congenital cardiac surgery.
    Suzuki Y; Yamauchi S; Daitoku K; Fukui K; Fukuda I
    ASAIO J; 2009; 55(1):53-7. PubMed ID: 19092671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful use of recombinant factor VIIa in a patient with intractable bleeding during extracorporeal membrane oxygenation.
    Brose S; Sirbu H; Engel M; Kuhlen R; Autschbach R
    Thorac Cardiovasc Surg; 2005 Dec; 53(6):389-90. PubMed ID: 16311981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombotic risk of recombinant factor seven in pediatric cardiac surgery: a single institution experience.
    Karsies TJ; Nicol KK; Galantowicz ME; Stephens JA; Kerlin BA
    Ann Thorac Surg; 2010 Feb; 89(2):570-6. PubMed ID: 20103344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of recombinant factor VIIa for uncontrolled bleeding in neonates after cardiopulmonary bypass.
    Guzzetta NA; Huch S; Fernandez JD; Tosone SR; Miller BE
    Paediatr Anaesth; 2009 Apr; 19(4):364-70. PubMed ID: 19143947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of recombinant factor VIIa for refractory hemorrhage during extracorporeal membrane oxygenation.
    Dominguez TE; Mitchell M; Friess SH; Huh JW; Manno CS; Ravishankar C; Gaynor JW; Tabbutt S
    Pediatr Crit Care Med; 2005 May; 6(3):348-51. PubMed ID: 15857537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatal thrombosis with activated factor VII in a paediatric patient on extracorporeal membrane oxygenation.
    Chalwin RP; Tiruvoipati R; Peek GJ
    Eur J Cardiothorac Surg; 2008 Sep; 34(3):685-6. PubMed ID: 18579402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indication for initiation of mechanical circulatory support impacts survival of infants with shunted single-ventricle circulation supported with extracorporeal membrane oxygenation.
    Allan CK; Thiagarajan RR; del Nido PJ; Roth SJ; Almodovar MC; Laussen PC
    J Thorac Cardiovasc Surg; 2007 Mar; 133(3):660-7. PubMed ID: 17320562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.